These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25730680)

  • 41. Bevacizumab for neovascular ocular diseases.
    Lynch SS; Cheng CM
    Ann Pharmacother; 2007 Apr; 41(4):614-25. PubMed ID: 17355998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
    Seibel I; Hager A; Riechardt AI; Davids AM; Böker A; Joussen AM
    Am J Ophthalmol; 2016 Aug; 168():31-39. PubMed ID: 27163234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current intravitreal pharmacologic therapies for diabetic macular edema.
    Colucciello M
    Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab.
    Ittiara S; Blair MP; Shapiro MJ; Lichtenstein SJ
    J AAPOS; 2013 Jun; 17(3):323-5. PubMed ID: 23607977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Radiation-induced retinopathy: actual knowledge and new concepts].
    Gilli C; Thariat J; Chacun S; Nguyen AM; Loria O; Kodjikian L; Mathis T
    Cancer Radiother; 2022 Nov; 26(8):1090-1099. PubMed ID: 35879145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.
    Kim HD; Kang KD; Choi KS; Rhee MR; Lee SJ
    Acta Ophthalmol; 2014 Nov; 92(7):e589-90. PubMed ID: 24866832
    [No Abstract]   [Full Text] [Related]  

  • 51. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.
    Zhou S; Gao J; Xu X
    Clin Exp Ophthalmol; 2014; 42(7):637-49. PubMed ID: 24330277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A; Dorta P
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiation retinopathy secondary to treatment of maxillary sinus carcinoma: a dramatic case.
    Galindo-Bocero J; Macías-Franco S; Sánchez-García S; Fonollá-Gil M; García-Alonso A
    Arch Soc Esp Oftalmol; 2017 Oct; 92(10):486-489. PubMed ID: 28185695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multifocal outer retinopathy in a patient with multifocal inner choroidopathy.
    Chen FK; Tufail A
    Clin Exp Ophthalmol; 2011; 39(7):700-3. PubMed ID: 22452687
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema.
    Penha FM; Maia M; Cardillo JA; Arevalo JF; Wu L; Rodriguez FJ; Berrocal MH; Farah ME;
    Acta Ophthalmol; 2012 Mar; 90(2):e160-1. PubMed ID: 21470386
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination therapy in diabetic macular oedema and retinal vein occlusion--past and present.
    Koss MJ; Naser H; Sener A; Ackermann H; Al-Sarireh F; Singh P; Koch FH
    Acta Ophthalmol; 2012 Sep; 90(6):580-9. PubMed ID: 20636486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetic macular oedema in 2011: what are the options for refractory cystic oedema?
    Wickremasinghe S
    Clin Exp Ophthalmol; 2011; 39(7):595-7. PubMed ID: 22452678
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk of radiation retinopathy in patients with orbital and ocular lymphoma.
    Kaushik M; Pulido JS; Schild SE; Stafford S
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1145-50. PubMed ID: 22592046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.